🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07247591
Starting soon Observational

Adductor Canal Localization in Living and Cadaver

NCT07247591 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-11-25
Last updated
2025-11-25

Condition(s) studied

AnatomyAdductor Canal Block

Study summary

The aim of this study is to define the starting and ending points of the adductor canal in adductor canal block (ACB) applications through distance measurements relative to the anterior superior iliac spine (ASIS) and the adductor tubercle. These measurements are performed using ultrasound (USG) and correlated with cadaveric data.

Key research questions addressed include:

* Can the start and end points of the adductor canal be formulated along a line drawn between the ASIS and the adductor tubercle?
* Is there a definable relationship between the block application site and anatomical landmarks such as the vastoadductor membrane (VAM), the apex of the femoral triangle, and other adjacent structures that facilitates localization?

By validating ultrasound measurements with cadaveric findings, the study aims to provide researchers with a more predictable and reliable method for determining the optimal site for adductor canal block administration.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: ASA 1-2-3 patients BMI \<35 Ages 18-65 Those willing to participate in the study Exclusion Criteria: Those unwilling to participate in the study Pregnant women BMI \>35 ASA 4-5-6 patients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Etlik City Hospital Ankara Turkey (Türkiye)

More Ankara Etlik City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07247591 on ClinicalTrials.gov ↗ ← All trials in Turkey